All articles by Emma Davies – Page 7
-
News
Chemical concerns for MEPs
Being a member of the European Parliament (MEP) could be a risky occupation.
-
News
Raising a toast to cholesterol
Spanish researchers suggest that sherry can help lower cholesterol.
-
News
Sanofi-Aventis emerges
Aventis has finally accepted a bid from its French rival Sanofi Synthélabo.
-
News
Ionic liquids: what the Heck is the promise?
Ionic liquids (ILs) are often hailed as the green saviours of organic chemistry.
-
News
Robins spark a pigment of the imagination
Evidence suggests that radical-pair theory guides migratory birds on their way.
-
News
Reaching for an opportunity
The UK chemical industry should see the impending Registration, Evaluation and Authorisation of Chemicals (Reach) legislation as 'an opportunity, not a threat'.
-
News
Bernard Henbest (1924-2004)
Bernard Henbest took up the chair of organic chemistry at Queen's University Belfast in 1958 at the age of 33.
-
News
Vernalis buys back migraine drug
Vernalis, the biotech company formed from the merger of British Biotech and the original Vernalis, has bought back the rights to its migraine drug from Irish biotech firm Elan.
-
News
Double beam dream
Researchers at Rutherford Appleton Laboratory in Oxfordshire, UK, are developing what they claim to be the 'most intense laser in the world'.
-
News
Getting personal with biotechnology
Personalised medicine, which promises to prevent, detect and cure diseases by linking the mechanisms and pathways of illnesses to individuals, will become a reality 'in our lifetime'.
-
News
Copycat chemistry disarms bugs
Researchers develop protein copies which make bacteria impotent.
-
News
Therapeutic target for alcohol abuse
US researchers raise hopes of new treatment for alcoholism.
-
News
Hydrocarbons aid ants in queen worship
Gas chromatography reveals why worker ants destroy their eggs.
-
News
Astex deal
Astex, a UK drug discovery company, has set up a multi-target drug discovery agreement with Boehringer Ingelheim (BI), a German pharmaceutical firm.